Atlas Trials

Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer

Clinical trial NCT03298763 · UNKNOWN

Trial details

NCT number
NCT03298763
Sponsor
University College, London
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Adenocarcinoma of Lung
Start date
2019-03-05
Primary completion
2023-09-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.